Pulse Biosciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Pulse Biosciences Stock Summary

Pulse Biosciences competes with InfuSystems Holdings, Repro Med, Milestone Scientific, Pro Dex, and OraSure Technologies. Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California. Pulse Biosciences operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 142 people.

Pulse Biosciences Key Financial Ratios

Pulse Biosciences Key Balance Sheet Accounts

Pulse Biosciences Key Income Statement Accounts

Pulse Biosciences Key Cash Accounts

Pulse Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Pulse Biosciences's current stock value. Our valuation model uses many indicators to compare Pulse Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pulse Biosciences competition to find correlations between indicators driving Pulse Biosciences's intrinsic value. More Info.Pulse Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Pulse Biosciences' Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Pulse Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Pulse Biosciences Systematic Risk

Today, most investors in Pulse Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Pulse Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Pulse Biosciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Pulse Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pulse Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pulse Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Pulse Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pulse Biosciences's daily price indicators and compare them against related drivers.

When running Pulse Biosciences' price analysis, check to measure Pulse Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulse Biosciences is operating at the current time. Most of Pulse Biosciences' value examination focuses on studying past and present price action to predict the probability of Pulse Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulse Biosciences' price. Additionally, you may evaluate how the addition of Pulse Biosciences to your portfolios can decrease your overall portfolio volatility.